Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age ≥ 65 Years”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT03742297
What this trial is testing

Treatment for Elderly Fit Newly Diagnosed Multiple Myeloma Patients Aged Between 65 and 80 Years

Who this might be right for
Newly Diagnosed Multiple Myeloma
PETHEMA Foundation 462
Testing effectiveness (Phase 2)Study completedNCT01849783
What this trial is testing

Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma

Who this might be right for
Extramedullary PlasmacytomaIsolated Plasmacytoma of BoneLight Chain Deposition Disease+4 more
Margarida Magalhaes-Silverman 41
Post-approval studies (Phase 4)Looking for participantsNCT07485283
What this trial is testing

Recombinant Herpes Zoster Vaccine for Prevention of Cardiovascular Events and Dementia

Who this might be right for
Cardiovascular DiseaseDementia
Tor Biering-Sørensen 162,000
Large-scale testing (Phase 3)Study completedNCT00562354
What this trial is testing

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Japanese Adults Aged >= 50 Years

Who this might be right for
Healthy
Pfizer 271
Post-approval studies (Phase 4)Study completedNCT05731115
What this trial is testing

Lot-to-lot Consistency of 23-valent Pneumococcal Polysaccharide Vaccine

Who this might be right for
Pneumococcal Infections
Sinovac Biotech Co., Ltd 1,800
Large-scale testing (Phase 3)Study completedNCT05071313
What this trial is testing

An Ad26.RSV.preF-based Vaccine and High-dose Seasonal Influenza Vaccine, With and Without Coadministration, in Adults Aged 65 Years and Older

Who this might be right for
Influenza, Human PreventionRespiratory Syncytial Viruses Prevention
Janssen Vaccines & Prevention B.V. 777
Not applicableStudy completedNCT03574480
What this trial is testing

Smartphone Applications to Improve Lifestyles in Olders Over 65 Years

Who this might be right for
Telemedicine
Fundacion para la Investigacion y Formacion en Ciencias de la Salud 140
Not applicableStudy completedNCT05870046
What this trial is testing

Effectiveness of Power Training in Older Women With Pre-sarcopenia

Who this might be right for
Pre-sarcopeniaOld Age; Debility
University of Salamanca 120
Not applicableStudy completedNCT03968536
What this trial is testing

Measuring the Impact of a Multimodal Intervention on Falls and Fear Falls Among People 65 Years Old, Residents at Home

Who this might be right for
FallOld Age; Atrophy
Gérond'if 71
Post-approval studies (Phase 4)Study completedNCT04622293
What this trial is testing

A Trial of Solriamfetol in the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Who this might be right for
Chronic Fatigue SyndromeMyalgic Encephalomyelitis
Rochester Center for Behavioral Medicine 44
Testing effectiveness (Phase 2)Study completedNCT07582328
What this trial is testing

Learn More About How Well Oxymetazoline HCl 0.05% Nasal Gel Works and How Safe It Is in Healthy Adults

Who this might be right for
Nasal Congestion, Nasal Obstruction
Bayer 120
Not applicableUnknownNCT06207838
What this trial is testing

Transition of T1DM Patients Aged Over 65 Years Into AHCL (780G) Insulin Pump

Who this might be right for
Diabetes Type 1
Jagiellonian University 30
Not applicableLooking for participantsNCT06029933
What this trial is testing

Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years

Who this might be right for
InfluenzaCommunity-acquired PneumoniaCardiovascular Events
Kaiser Permanente 1,500,000
Not applicableUnknownNCT00884208
What this trial is testing

Fall Risk Prediction and Reduction in Community Ambulators 65 Years of Age or Older

Who this might be right for
Accidental FallsElderlyAmbulatory
Guthrie Healthcare System 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT07743008
What this trial is testing

Phase 2 Trial of a Haemophilus Influenzae Serotype a (Hia) Glycoconjugate Vaccine

Who this might be right for
Haemophilus InfluenzaeHaemophilus Influenzae Type a
InventVacc Biologicals Inc. 47
Large-scale testing (Phase 3)Looking for participantsNCT06229288
What this trial is testing

Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward

Who this might be right for
Community-acquired Pneumonia
Nantes University Hospital 326
Post-approval studies (Phase 4)Study completedNCT02189603
What this trial is testing

Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine（Hecolin®）

Who this might be right for
Hepatitis E
Jun Zhang 601
Testing effectiveness (Phase 2)Looking for participantsNCT06022159
What this trial is testing

Evaluate Pre-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years Old) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa.

Who this might be right for
Soft Tissue Sarcoma
Institut Claudius Regaud 48
Not applicableNot Yet RecruitingNCT07659470
What this trial is testing

RANDOMIZED CONTROLLED TRIAL OF TEXT MESSAGE TO INCREASE PNEUMOCOCCAL VACCINATION IN ADULTS IN CHILE.

Who this might be right for
Pneumococcal InfectionsImmunization ProgramsVaccination Coverage+4 more
Pablo Tomás Valenzuela García 43,000
Testing effectiveness (Phase 2)Study completedNCT04192500
What this trial is testing

Safety and Immune Response of One Dose of OVX836 at Two Dose Levels, in Comparison to Influvac TetraTM, After Intramuscular Administration in Healthy Subjects Aged 18-65 Years

Who this might be right for
Influenza
Osivax 300
Next Page